leisure time -WSS

leisure time

author：entertainment 2025-09-30 18:48:08 - browse：735

An light blue number 3 with an eye is surrounded by smaller, black number 3s on an orange background — 3 to watch coverage from STAT — Christine Kao/STAT

It’s been a slow year for medtech. Major deals in 2023 were scarce, funding was hard to come by, and valuations were down. On the policy side, the industry grappled with changing AI regulations, reimbursement woes, and device sterilization rules.

Here are three political and market forces that shaped the medtech industry last year, and are worth paying attention to in 2024:

Lobbying power of AI, software-enabled devices

Medtech lobby AdvaMed announced earlier this month that the major medical imaging companies, previously housed within the National Electrical Manufacturers Association, were shifting to their shop. The device group also created a separate niche for digital health companies in October.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 5 ways to address the shortage of health care workers

WSS

JPM: CVS says Medicare Advantage patients are impacting profits

Childhood vaccination ad campaign launches in the U.K.

Ohio train derailment: Experts on toxic chemical risks

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

3 medical device trends to watch in 2024

3 medical device trends to watch in 2024

entertainment

leisure time

Lobbying power of AI, software-enabled devices

hotspot

What does generative AI mean for health care? We asked experts

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

The high cost of giving birth even with insurance

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Dobbs anniversary: the lost opportunity of abortion as health care

Virtual repurposing can help discover new uses for existing drugs

Cancer drug shortages should be causing more outrage

Redefining sustainability for the pharmaceutical industry

leisure time

Redefining sustainability for the pharmaceutical industry

The FDA must approve intranasal treatments for anaphylaxis

CDC advisory group OKs chikungunya vaccine

Morgan Health, with ambitious aims, wants you to know it’s still here

CDC advisory group OKs chikungunya vaccine

Doctor of U.S. President Joe Biden says he is fit for duty

knowledge

hotspot

hotspot

hotspot